Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Enterprise Value

The Enterprise Value (EV) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 17.12 B CNY. In the previous year, Enterprise Value (EV) was 15.96 B CNY — a change of 7.27% (higher).

Enterprise Value

17.12 BCNY

YoY

7.27%

Last updated:

Enterprise Value (EV) of Jinyu Bio-Technology Co is 2025 17.12 B CNY. Enterprise Value (EV) of Jinyu Bio-Technology Co was 2024 15.96 B CNY. It decreases by 7.27% higher compared to the previous year.

The Jinyu Bio-Technology Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
15.40 B CNY
Jan 1, 2019
15.38 B CNY
Jan 1, 2020
15.07 B CNY
Jan 1, 2021
15.61 B CNY
Jan 1, 2022
15.68 B CNY
Jan 1, 2023
15.38 B CNY
Jan 1, 2024
15.96 B CNY
Jan 1, 2025
17.12 B CNY
The Jinyu Bio-Technology Co Enterprise Value history
YEAREnterprise ValueYoY
17.12 BCNY+7.27%
15.96 BCNY+3.82%
15.38 BCNY-1.95%
15.68 BCNY+0.49%
15.61 BCNY+3.59%
15.07 BCNY-2.06%
15.38 BCNY-0.10%
15.40 BCNY+4.93%
14.67 BCNY-0.33%
14.72 BCNY-8.52%
16.09 BCNY-0.50%
16.18 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Enterprise Value (EV) of Jinyu Bio-Technology Co is 17.12 B CNY in 2025.

Enterprise Value (EV) of Jinyu Bio-Technology Co changed from 15.96 B CNY to 17.12 B CNY, representing a 7.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s CNY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' CNY varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Jinyu Bio-Technology Co

All Key Metrics — Jinyu Bio-Technology Co